Article
Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass
18 Nov 2019
Abstract excerpt
BACKGROUND: Ovarian cancer is the fifth most common cancer in women worldwide. Moreover, there are no reliable minimal invasive tests to secure the diagnosis of malignant pelvic masses. Cell-free, circulating microRNAs have the potential as diagnostic biomarkers in cancer. Here, we performed and validated a miRNA panel with the potential to distinguish OC from benign pelvic masses. METHODS: The profile of plasma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
